Prescription Drug Abuse Rates Hound Providers
Twillman wants more physicians to be trained in pain management, a sentiment echoed by the American Society of Interventional Pain Physicians. Both ASIPP and AAPM are trumpeting training programs over a new proposal that changes labeling requirements on opioids.
PROP, Physicians for Responsible Opioid Prescribing, criticizes the labels for being too broad, and giving neither a time frame for use, nor a maximum dose for non-cancer pain. It wants opioid labels changed and has asked the FDA for three specific modifications:
- Strike the term "moderate" from the indication for non-cancer pain
- Add a maximum daily dose, equivalent to 100 milligrams of morphine for non-cancer pain
- Add a maximum duration of 90-days for continuous (daily) use for non-cancer pain
Andrew Kolodny, President of PROP, says its aim is not to stop doctors from prescribing painkillers when necessary. It wants to stop drug companies from promoting the drugs aggressively.
"The label changes will prohibit advertising but will not limit clinical decision making. If a doctor believes that a patient might benefit from long-term opioids, they will be permitted to prescribe. Off-label use of medications is very common and is often considered to be perfectly appropriate," Kolodny says.
- CMS Mulls Income-Adjusting MA Stars
- As Retail Clinics Surge, Quality Metrics MIA
- Providers Prep for New Payment Models as Population Health Grows
- Providers' Push to Consolidate Roils Payers
- 3 Ways to Rev Employee Development Programs
- Former NQF Co-Chair Linked to Conflicts of Interest in Journal Probe
- No Employee Satisfaction, No Patient-Centered Culture
- 6 Not-So-Good Reasons for Avoiding Population Health
- Transforming Decision Support and Reporting
- Aligning Executive Compensation with Provider Mission